Hypervirulent Clostridium difficile PCR-Ribotypes Exhibit Resistance to Widely Used Disinfectants

被引:54
作者
Dawson, Lisa F. [1 ]
Valiente, Esmeralda [1 ]
Donahue, Elizabeth H. [1 ]
Birchenough, George [1 ]
Wren, Brendan W. [1 ]
机构
[1] London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1, England
来源
PLOS ONE | 2011年 / 6卷 / 10期
基金
英国惠康基金;
关键词
ANTIBIOTIC-ASSOCIATED COLITIS; INFECTION; EPIDEMIOLOGY; BIOCIDE; CONTAMINATION; ENVIRONMENT; DIARRHEA; STRAINS; TRICLOSAN; MORTALITY;
D O I
10.1371/journal.pone.0025754
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The increased prevalence of Clostridium difficile infection (CDI) has coincided with enhanced transmissibility and severity of disease, which is often linked to two distinct clonal lineages designated PCR-ribotype 027 and 017 responsible for CDI outbreaks in the USA, Europe and Asia. We assessed sporulation and susceptibility of three PCR-ribotypes; 012, 017 and 027 to four classes of disinfectants; chlorine releasing agents (CRAs), peroxygens, quaternary ammonium compounds (QAC) and biguanides. The 017 PCR-ribotype, showed the highest sporulation frequency under these test conditions. The oxidizing biocides and CRAs were the most efficacious in decontamination of C. difficile vegetative cells and spores, the efficacy of the CRAs were concentration dependent irrespective of PCR-ribotype. However, there were differences observed in the susceptibility of the PCR-ribotypes, independent of the concentrations tested for Virkon (R), Newgenn (R), Proceine 40 (R) and Hibiscrub (R). Whereas, for Steri7 (R) and Biocleanse (R) the difference observed between the disinfectants were dependent on both PCR-ribotype and concentration. The oxidizing agent Perasafe (R) was consistently efficacious across all three PCR ribotypes at varying concentrations; with a consistent five Log10 reduction in spore titre. The PCR-ribotype and concentration dependent differences in the efficacy of the disinfectants in this study indicate that disinfectant choice is a factor for llimiting the survival and transmission of C. difficile spores in healthcare settings.
引用
收藏
页数:7
相关论文
共 44 条
  • [1] CLOSTRIDIUM-DIFFICILE - HISTORY OF ITS ROLE AS AN ENTERIC PATHOGEN AND THE CURRENT STATE OF KNOWLEDGE ABOUT THE ORGANISM
    BARTLETT, JG
    [J]. CLINICAL INFECTIOUS DISEASES, 1994, 18 : S265 - S272
  • [2] Historical perspectives on studies of Clostridium difficile and C difficile infection
    Bartlett, John G.
    [J]. CLINICAL INFECTIOUS DISEASES, 2008, 46 : S4 - S11
  • [3] The Potential for Airborne Dispersal of Clostridium difficile from Symptomatic Patients
    Best, Emma L.
    Fawley, Warren N.
    Parnell, Peter
    Wilcox, Mark H.
    [J]. CLINICAL INFECTIOUS DISEASES, 2010, 50 (11) : 1450 - 1457
  • [4] Block SS, 1991, DISINFECTION STERILI, V4th, P167
  • [5] CERAGIOLI M, 2010, APPL ENV MICROBIOL
  • [6] Clostridium difficile PCR ribotype 027: assessing the risks of further worldwide spread
    Clements, Archie C. A.
    Magalhaes, Ricardo J. Soares
    Tatem, Andrew J.
    Paterson, David L.
    Riley, Thomas V.
    [J]. LANCET INFECTIOUS DISEASES, 2010, 10 (06) : 395 - 404
  • [7] Clinical Clostridium difficile: Clonality and Pathogenicity Locus Diversity
    Dingle, Kate E.
    Griffiths, David
    Didelot, Xavier
    Evans, Jessica
    Vaughan, Alison
    Kachrimanidou, Melina
    Stoesser, Nicole
    Jolley, Keith A.
    Golubchik, Tanya
    Harding, Rosalind M.
    Peto, Tim E.
    Fawley, Warren
    Walker, A. Sarah
    Wilcox, Mark
    Crook, Derrick W.
    [J]. PLOS ONE, 2011, 6 (05):
  • [8] DRUDY D, 2006, J ANTIMICROB CHEMOTH
  • [9] EPIDEMIOLOGY OF ANTIBIOTIC-ASSOCIATED COLITIS - ISOLATION OF CLOSTRIDIUM DIFFICLE FROM THE HOSPITAL ENVIRONMENT
    FEKETY, R
    KIM, KH
    BROWN, D
    BATTS, DH
    CUDMORE, M
    SILVA, J
    [J]. AMERICAN JOURNAL OF MEDICINE, 1981, 70 (04) : 906 - 908
  • [10] Biocide abuse and antimicrobial resistance - a cause for concern?
    Fraise, AP
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2002, 49 (01) : 11 - 12